Jiping Liu

1.5k total citations · 1 hit paper
44 papers, 1.0k citations indexed

About

Jiping Liu is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Jiping Liu has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 10 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Jiping Liu's work include Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Neurological Disease Mechanisms and Treatments (8 papers) and Allergic Rhinitis and Sensitization (3 papers). Jiping Liu is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Neurological Disease Mechanisms and Treatments (8 papers) and Allergic Rhinitis and Sensitization (3 papers). Jiping Liu collaborates with scholars based in China, United States and Canada. Jiping Liu's co-authors include Qiang Fu, Shiping Ma, Harold E. Burkhart, Ralph L. Amateis, Liang Feng, Rong Qu, Shiping Ma, Zhou Lan, Liqiang Zhou and Chunhua Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.

In The Last Decade

Jiping Liu

39 papers receiving 1.0k citations

Hit Papers

Temporal and spatial cellular and molecular pathological ... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiping Liu China 19 398 171 157 151 130 44 1.0k
Min Xu China 20 553 1.4× 136 0.8× 111 0.7× 58 0.4× 76 0.6× 94 1.4k
Hyun‐Jin Tae South Korea 21 494 1.2× 266 1.6× 184 1.2× 90 0.6× 146 1.1× 99 1.4k
Tao Tao China 18 490 1.2× 242 1.4× 110 0.7× 77 0.5× 74 0.6× 52 1.2k
Zhi Ma China 24 690 1.7× 293 1.7× 130 0.8× 97 0.6× 90 0.7× 43 1.4k
Ziwei Zhou China 16 685 1.7× 186 1.1× 171 1.1× 61 0.4× 55 0.4× 64 1.5k
Fei Xu China 25 520 1.3× 62 0.4× 204 1.3× 198 1.3× 214 1.6× 71 1.6k
Cansheng Zhu China 21 311 0.8× 191 1.1× 155 1.0× 37 0.2× 70 0.5× 42 1.0k
Yen‐Hsuan Jean Taiwan 25 356 0.9× 48 0.3× 168 1.1× 56 0.4× 87 0.7× 46 1.4k
Yasong Li China 14 382 1.0× 183 1.1× 115 0.7× 27 0.2× 125 1.0× 33 956

Countries citing papers authored by Jiping Liu

Since Specialization
Citations

This map shows the geographic impact of Jiping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiping Liu more than expected).

Fields of papers citing papers by Jiping Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiping Liu. The network helps show where Jiping Liu may publish in the future.

Co-authorship network of co-authors of Jiping Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiping Liu. A scholar is included among the top collaborators of Jiping Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiping Liu. Jiping Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Chao, Benhong Xu, Yue Hu, et al.. (2025). Designing novel nucleoside inhibitors targeting the allosteric site of PBP2a: A strategic approach to overcome resistance in MRSA. Bioorganic & Medicinal Chemistry. 122. 118133–118133. 2 indexed citations
3.
Zhang, Jiahao, Lu Zhao, Andong Zhao, et al.. (2024). Baicalin-Geniposide glycosides inhibit PM2.5-induced brain damage in rats via the 5-LOX/LTB4 pathway. Molecular Immunology. 177. 62–72. 2 indexed citations
4.
He, Yifan, Hailong Shi, Xingmei Zhu, et al.. (2024). Investigating the molecular mechanism of vitexin targeting CDK1 to inhibit colon cancer cell proliferation via GEO chip data mining, computer simulation, and biological activity verification. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(2). 1637–1652. 2 indexed citations
5.
Liu, Yuwen, Jiping Liu, Zhengrong Li, et al.. (2024). Classical prescription Daqinjiao decoction inhibit cerebral ischemia/reperfusion induced necroptosis and ferroptosis through multiple mechanisms. Journal of Ethnopharmacology. 340. 119300–119300. 3 indexed citations
7.
Gao, Ying, Wenqiang Yu, Jiping Liu, et al.. (2022). Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis. Frontiers in Pharmacology. 13. 940716–940716. 22 indexed citations
8.
Ding, Ting, Chun-Mei Deng, Xiaofeng Shen, et al.. (2022). Effect of a carbohydrate-rich beverage on rate of cesarean delivery in primigravidae with epidural labor analgesia: a multicenter randomized trial. BMC Pregnancy and Childbirth. 22(1). 339–339. 1 indexed citations
9.
Li, Chen, Zhourui Wu, Liqiang Zhou, et al.. (2022). Temporal and spatial cellular and molecular pathological alterations with single-cell resolution in the adult spinal cord after injury. Signal Transduction and Targeted Therapy. 7(1). 65–65. 148 indexed citations breakdown →
10.
Yan, Xinfeng, Jiping Liu, Fengwen Li, et al.. (2021). ATF5, a putative therapeutic target for the mitochondrial DNA 3243A > G mutation-related disease. Cell Death and Disease. 12(7). 701–701. 16 indexed citations
11.
Wang, Yan, et al.. (2021). Baicalin and Geniposide Inhibit Polarization and Inflammatory Injury of OGD/R-Treated Microglia by Suppressing the 5-LOX/LTB4 Pathway. Neurochemical Research. 46(7). 1844–1858. 29 indexed citations
12.
Zhou, Liqiang, Jiping Liu, Min Liu, et al.. (2020). Single-cell RNA-seq analysis revealed long-lasting adverse effects of tamoxifen on neurogenesis in prenatal and adult brains. Proceedings of the National Academy of Sciences. 117(32). 19578–19589. 31 indexed citations
13.
Jing, Bo, Chunxue Zhang, Xianjun Liu, et al.. (2017). Glycosylation of dentin matrix protein 1 is a novel key element for astrocyte maturation and BBB integrity. Protein & Cell. 9(3). 298–309. 21 indexed citations
14.
Liu, Jiping, Huina Zhang, Liqiang Zhou, et al.. (2017). Single-cell transcriptomics reveals gene signatures and alterations associated with aging in distinct neural stem/progenitor cell subpopulations. Protein & Cell. 9(4). 351–364. 44 indexed citations
15.
Liu, Jiping, et al.. (2015). CPU-12, a novel synthesized oxazolo[5,4-d]pyrimidine derivative, showed superior anti-angiogenic activity. Journal of Pharmacological Sciences. 129(1). 9–17. 12 indexed citations
16.
Tan, Xiaobin, Junfei Gu, Shuyuan Wang, et al.. (2014). Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats. Journal of Ginseng Research. 39(2). 116–124. 53 indexed citations
17.
Liu, Jiping, Shuyuan Wang, Liang Feng, et al.. (2013). Hypoglycemic and Antioxidant Activities of Paeonol and Its Beneficial Effect on Diabetic Encephalopathy in Streptozotocin-Induced Diabetic Rats. Journal of Medicinal Food. 16(7). 577–586. 52 indexed citations
19.
Liu, Jiping, Liang Feng, Dongying Ma, et al.. (2013). Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat. Neuroscience Letters. 549. 63–68. 65 indexed citations
20.
Lan, Zhou, Jiping Liu, Lvyi Chen, et al.. (2012). Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice. Journal of Ethnopharmacology. 141(1). 386–395. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026